Lux Capital, established in 2000, is a New York-based venture capital firm managing over $4 billion in assets. It invests in early-stage and growth companies at the intersection of technology and sciences, focusing on sectors such as biochemistry, material science, electronics, infrastructure, and aerospace. Lux actively supports entrepreneurs, having helped build over 20 companies from scratch, and employs a strategy that enhances portfolio companies' connectivity, insights, and industry leadership.
Jericho Security specializes in cybersecurity, focusing on protecting businesses from emerging threats posed by generative AI. The company's core product, cyberGPT, is a proprietary generative AI that simulates real-world cyberattacks, aids in developing new defenses, and provides personalized training to enhance cybersecurity efficiency and prevent potential threats.
Together AI
Series B in 2025
Together AI is a cloud-based platform designed for constructing open-source generative AI and infrastructure for developing AI models. The company contributes cutting-edge open-source research, models, and datasets to push the boundaries of AI forward. Through its decentralized cloud services, developers and researchers at organizations of various scales are empowered to train, refine, and deploy generative AI models.
Fiddler AI
Series B in 2024
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.
Enveda Biosciences
Series C in 2024
Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.
Physical Intelligence
Series A in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.
11x
Series A in 2024
11x is a technology company that specializes in developing autonomous digital workers aimed at optimizing organizational processes, particularly in go-to-market operations. By automating specific roles, 11x enables businesses to streamline their hiring budgets and enhance productivity. The company's primary offerings include Alice, an AI-powered sales development representative, and Jordan, both of which are part of its platform that provides customizable artificial intelligence workers. These digital workers are designed to perform tasks traditionally handled by knowledge workers, allowing organizations to improve efficiency and scale effectively as they grow.
Kinetic Automation
Series B in 2024
Kinetic Automation is transforming the automotive repair industry by developing an advanced infrastructure that integrates hardware, robotics, software, and artificial intelligence. The company focuses on providing mobility services specifically for electric and autonomous vehicles through its automated repair centers. Utilizing precision technology powered by machine learning, Kinetic aims to deliver rapid, accurate, and predictable maintenance solutions. Its innovative approach positions Kinetic as a key player in the future of automotive servicing, facilitating essential support for electric vehicle owners and enhancing the overall efficiency of vehicle maintenance.
Maven AGI
Series A in 2024
Maven AGI is a technology company specializing in modern artificial intelligence solutions. It focuses on revolutionizing customer support by employing AI to reduce costs, enhance speed and quality, and boost operational efficiency. The company's AI solutions empower teams to increase productivity and focus on tasks that require human expertise. Additionally, Maven AGI offers services such as customer acquisition strategy and operational planning. With a team of 50 employees across various roles, the company aims to transform customer support experiences.
LabGenius
Series B in 2024
LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.
Xaira Therapeutics
Venture Round in 2024
Xaira Therapeutics is an integrated biotechnology company focused on revolutionizing drug discovery and development through the application of artificial intelligence. Headquartered in the San Francisco Bay Area, Xaira combines expertise in machine learning, extensive biological and clinical data generation, and robust therapeutic product development. By harnessing advanced AI techniques, the company aims to enhance the understanding of biological processes and improve the effectiveness of therapies. Xaira's approach encompasses all stages of drug discovery, striving to transform how diseases are treated and enabling clients to deliver innovative therapeutic solutions.
Collaborative Robotics
Series B in 2024
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.
Together AI
Series A in 2024
Together AI is a cloud-based platform designed for constructing open-source generative AI and infrastructure for developing AI models. The company contributes cutting-edge open-source research, models, and datasets to push the boundaries of AI forward. Through its decentralized cloud services, developers and researchers at organizations of various scales are empowered to train, refine, and deploy generative AI models.
Physical Intelligence
Seed Round in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.
Sakana AI
Seed Round in 2024
Sakana AI is a research-focused company dedicated to developing innovative foundation models inspired by nature. It specializes in creating an AI model capable of generating text, images, video, code, and multimedia, facilitating collaborative research and development in generative AI. The company's AI development process emphasizes evolution and collective intelligence.
Inductive Bio
Seed Round in 2023
Inductive Bio specializes in providing a machine learning platform that enhances the compound optimization process for drug development. The company focuses on addressing ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) challenges by building comprehensive datasets and machine learning models. This enables scientists to efficiently identify and refine small molecule compounds, transforming initial candidates into viable leads more rapidly and with improved properties. By streamlining the optimization process, Inductive Bio supports the development of new therapeutics, ultimately contributing to advancements in the pharmaceutical industry.
Modal Labs
Series A in 2023
Modal Labs is a technology company that specializes in machine learning software designed to facilitate code execution in the cloud. Its platform allows users to deploy machine learning models, run massively parallel compute jobs, manage task queues, and host web applications. By utilizing containers, Modal's software automates the provisioning of compute instances, hardware accelerators, and cloud storage. This enables data science teams to concentrate on developing their models and applications without the burden of managing intricate infrastructure, thereby enhancing efficiency and performance in cloud-based computing environments.
Kinetic Automation
Series A in 2023
Kinetic Automation is transforming the automotive repair industry by developing an advanced infrastructure that integrates hardware, robotics, software, and artificial intelligence. The company focuses on providing mobility services specifically for electric and autonomous vehicles through its automated repair centers. Utilizing precision technology powered by machine learning, Kinetic aims to deliver rapid, accurate, and predictable maintenance solutions. Its innovative approach positions Kinetic as a key player in the future of automotive servicing, facilitating essential support for electric vehicle owners and enhancing the overall efficiency of vehicle maintenance.
Delphi
Seed Round in 2023
Delphi is a digital cloning platform designed to capture and replicate individual thoughts, insights, and experiences. This innovative platform allows users to access personalized knowledge and advice tailored to their unique perspectives. By harnessing the information and opinions of various individuals, Delphi facilitates personalized learning and development, enabling users to benefit from the expertise available across the internet. The platform aims to make valuable insights readily available to others, enhancing their decision-making and personal growth.
Jericho Security
Pre Seed Round in 2023
Jericho Security specializes in cybersecurity, focusing on protecting businesses from emerging threats posed by generative AI. The company's core product, cyberGPT, is a proprietary generative AI that simulates real-world cyberattacks, aids in developing new defenses, and provides personalized training to enhance cybersecurity efficiency and prevent potential threats.
Together AI
Seed Round in 2023
Together AI is a cloud-based platform designed for constructing open-source generative AI and infrastructure for developing AI models. The company contributes cutting-edge open-source research, models, and datasets to push the boundaries of AI forward. Through its decentralized cloud services, developers and researchers at organizations of various scales are empowered to train, refine, and deploy generative AI models.
Mythic
Venture Round in 2023
Mythic Inc. is a technology company that designs and develops silicon chips and artificial intelligence processing units (IPUs) for a wide range of applications, from consumer electronics and wearables to autonomous vehicles and robotic drones. Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic specializes in analog matrix processors that utilize unique compute-in-memory technology. Their products, including the M1076 Analog Matrix Processor and various PCIe and M.2 cards, integrate AI capabilities directly into compact chips, enabling desktop-level processing power in smaller devices. The company emphasizes its expertise in neural networks, processor architecture, and software design to deliver efficient AI solutions while maintaining performance, power efficiency, and accuracy in real-world environments.
Paradigm
Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.
Enveda Biosciences
Series B in 2022
Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.
Anagenex
Series A in 2022
Anagenex is a seed stage biotechnology company focused on advancing drug discovery through its innovative platform. The company aims to tackle challenging pharmaceutical targets by utilizing a technology that combines machine learning with DNA-encoded libraries. This approach allows for the rapid analysis of compounds and the generation of extensive data sets, facilitating parallel biochemical experiments. By leveraging proprietary artificial intelligence models, Anagenex enables researchers to efficiently develop new small molecule drugs for medically significant applications.
LatchBio
Series A in 2022
LatchBio is a company that specializes in developing a bioinformatics platform aimed at supporting cell and gene therapy startups. Established in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, LatchBio provides an open-source machine learning and cloud infrastructure tailored for the biotech sector. Its platform modernizes the computing capabilities available to biotech labs by offering custom workflows, pipelines, and machine learning models that can be utilized across various scales. This infrastructure enables scientists to efficiently create bioinformatic queries without requiring extensive command-line knowledge or dealing with complex setups. By streamlining data integration and processing, LatchBio helps biotech companies accelerate therapeutic discovery and reduce engineering costs.
Hugging Face
Series C in 2022
Hugging Face, established in 2016 and based in New York, specializes in open-source machine learning technologies. It operates a platform that facilitates collaboration on machine learning projects, including models, datasets, and applications. The company aims to democratize machine learning by providing tools and services that support and advance the field, while also offering paid computing and enterprise systems to accelerate development.
Alife
Series A in 2022
Alife is a health technology company that focuses on using artificial intelligence to enhance the success rates of pregnancy for individuals undergoing fertility treatments. Founded in 2020 by Paxton Maeder-York and based in San Francisco, California, Alife aims to assist physicians in selecting the healthiest embryos through advanced deep learning and software development. By connecting fertility specialists with patients, the company seeks to improve the overall chances of achieving healthy pregnancies, ultimately supporting its mission of helping people have healthy children.
Creyon Bio
Series A in 2022
Creyon Bio is a pre-clinical stage company focused on advancing drug development through a data-driven methodology. It specializes in engineering RNA-based medicines and their components by creating proprietary datasets that inform advanced machine learning models. This innovative approach enables the rapid identification of design rules and engineering principles necessary for the development of safe and effective oligonucleotide-based medicines. By leveraging these insights, Creyon Bio aims to improve the efficiency of the drug development process, ultimately contributing to cost savings in the healthcare sector while catering to diverse patient populations.
Gandeeva Therapeutics
Series A in 2022
Gandeeva Therapeutics is a precision biotechnology company focused on developing innovative therapeutics by leveraging cryogenic electron microscopy and machine learning to target key protein-protein interactions. The company's structure-guided drug discovery platform includes target prediction and validation, hit identification through virtual and fragment library screening, and lead optimization. Gandeeva has established a strong preclinical oncology pipeline aimed at addressing challenging cancers with unique protein interaction modulators, including interfacial glues and allosteric inhibitors. Headquartered in the Greater Vancouver area, Canada, Gandeeva is dedicated to enhancing the drug discovery process and reducing the risk of late-stage clinical failures.
Anagenex
Seed Round in 2022
Anagenex is a seed stage biotechnology company focused on advancing drug discovery through its innovative platform. The company aims to tackle challenging pharmaceutical targets by utilizing a technology that combines machine learning with DNA-encoded libraries. This approach allows for the rapid analysis of compounds and the generation of extensive data sets, facilitating parallel biochemical experiments. By leveraging proprietary artificial intelligence models, Anagenex enables researchers to efficiently develop new small molecule drugs for medically significant applications.
Clarifai
Series C in 2021
Clarifai, Inc. is a prominent provider of advanced artificial intelligence solutions specializing in image recognition, natural language processing, and audio recognition. Founded in 2013 by Matt Zeiler, Ph.D., the company develops a deep learning platform that enables organizations to convert unstructured data—such as images, videos, text, and audio—into structured data efficiently and accurately. Clarifai's image recognition technology is capable of detecting near-duplicates, categorizing objects, and tagging images, while also allowing users to search for similar images within extensive uncategorized collections through a combination of semantic and visual similarity. Additionally, the company offers a labeling tool called Labeler, which aids in dataset labeling, AI training, and model auto-scaling in production environments. Headquartered in New York, with an office in Tallinn, Estonia, Clarifai employs a distributed team across various countries, including the United States, Canada, Argentina, and India.
MosaicML
Venture Round in 2021
MosaicML specializes in developing software infrastructure and algorithms aimed at enhancing the efficiency of training large language models and neural networks. The company focuses on employing algorithmic techniques, such as sparsity and network pruning, to optimize the training process. By doing so, MosaicML enables users to train large-scale artificial intelligence models more efficiently and cost-effectively within their secure environments, utilizing their proprietary data. This approach not only improves training speed and model quality but also reduces overall costs associated with model development.
LatchBio
Seed Round in 2021
LatchBio is a company that specializes in developing a bioinformatics platform aimed at supporting cell and gene therapy startups. Established in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, LatchBio provides an open-source machine learning and cloud infrastructure tailored for the biotech sector. Its platform modernizes the computing capabilities available to biotech labs by offering custom workflows, pipelines, and machine learning models that can be utilized across various scales. This infrastructure enables scientists to efficiently create bioinformatic queries without requiring extensive command-line knowledge or dealing with complex setups. By streamlining data integration and processing, LatchBio helps biotech companies accelerate therapeutic discovery and reduce engineering costs.
Primer
Series C in 2021
Primer Technologies, Inc., established in 2014 and headquartered in San Francisco, specializes in developing software that leverages machine learning and natural language processing to analyze vast amounts of textual data across multiple languages. Its platform automates the parsing and collation of documents, uncovering insights and generating reports comparable to those produced by human analysts. This enables governments and corporations to better understand and monitor global information, facilitating informed decision-making.
Enveda Biosciences
Series A in 2021
Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.
Fiddler AI
Series B in 2021
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.
Alife
Seed Round in 2021
Alife is a health technology company that focuses on using artificial intelligence to enhance the success rates of pregnancy for individuals undergoing fertility treatments. Founded in 2020 by Paxton Maeder-York and based in San Francisco, California, Alife aims to assist physicians in selecting the healthiest embryos through advanced deep learning and software development. By connecting fertility specialists with patients, the company seeks to improve the overall chances of achieving healthy pregnancies, ultimately supporting its mission of helping people have healthy children.
DeepSpin
Convertible Note in 2021
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.
Hugging Face
Series B in 2021
Hugging Face, established in 2016 and based in New York, specializes in open-source machine learning technologies. It operates a platform that facilitates collaboration on machine learning projects, including models, datasets, and applications. The company aims to democratize machine learning by providing tools and services that support and advance the field, while also offering paid computing and enterprise systems to accelerate development.
LabGenius
Series A in 2020
LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.
Recursion Pharmaceuticals
Series D in 2020
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.
Thrive Earlier Detection
Series B in 2020
Thrive Earlier Detection Corp. is a healthcare company that specializes in developing advanced blood testing technologies for early cancer detection. Its flagship product, CancerSEEK, is a liquid biopsy test that analyzes genomic mutations in tumor DNA and protein markers in plasma, allowing for the identification of various cancers at their nascent stages, often before symptoms manifest. Founded in 2018 and headquartered in Cambridge, Massachusetts, with an additional office in Baltimore, Maryland, Thrive aims to integrate cancer screening into standard medical practice. The company leverages real-world data and machine learning to enhance the accuracy of cancer detection, facilitate follow-up testing, and streamline the transition to oncological care. Thrive operates as a subsidiary of Exact Sciences Corporation and has received investments from notable firms including Third Rock Ventures and Section 32.
Tecton
Series A in 2020
Tecton offers an enterprise-ready feature store that addresses the unique data requirements of machine learning. By providing a robust data platform, Tecton enables machine learning teams to efficiently build, serve, and scale features for production use. The platform allows users to construct features from various data sources, including batch, streaming, and real-time data, facilitating the sharing, reuse, and deployment of models. This capability empowers data scientists and organizations to automate decisions at high speed, enhance customer experiences, and transform business processes. Tecton's focus on optimizing the data layer for machine learning aims to help companies develop superior models more rapidly, driving significant business outcomes.
Rosebud AI
Seed Round in 2020
Rosebud AI, Inc. is a San Francisco-based company that specializes in developing software for creating digital avatars and models tailored for various uses. The platform allows users to customize avatars based on demographic factors, age, and style, making it accessible for a wide range of applications. Additionally, Rosebud AI focuses on generating artificial intelligence-driven game assets, simplifying the process of visual content creation for creators. The software enables users to effortlessly produce non-fungible token (NFT) collections without requiring prior experience in smart contracts or web3 technologies. By integrating established computer graphics techniques with advanced AI research, the company also offers tools for animating old photos and enhancing artistic creations, thereby enriching the digital content landscape.
Hugging Face
Series A in 2019
Hugging Face, established in 2016 and based in New York, specializes in open-source machine learning technologies. It operates a platform that facilitates collaboration on machine learning projects, including models, datasets, and applications. The company aims to democratize machine learning by providing tools and services that support and advance the field, while also offering paid computing and enterprise systems to accelerate development.
Orbital Insight
Series D in 2019
Orbital Insight, Inc. is a geospatial analytics company based in Palo Alto, California, established in 2013. The firm develops a cloud-based platform that employs artificial intelligence and machine learning to analyze vast amounts of geospatial data, including satellite imagery, mobile location signals, and other Internet of Things data. This technology enables organizations, including businesses, governments, and NGOs, to gain insights into societal and economic trends that may not be visible to the naked eye. Orbital Insight's products, such as Orbital Insight GO, GO Consumer, and GO Energy, provide users with actionable intelligence regarding infrastructure, supply chain dynamics, and energy resources. By transforming billions of data points into clear, usable information, the company supports data-driven decision-making in various sectors.
Fiddler AI
Venture Round in 2019
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.
LabGenius
Series A in 2019
LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.
Fiddler AI
Series A in 2019
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.
Recursion Pharmaceuticals
Series C in 2019
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.
Mythic
Series B in 2019
Mythic Inc. is a technology company that designs and develops silicon chips and artificial intelligence processing units (IPUs) for a wide range of applications, from consumer electronics and wearables to autonomous vehicles and robotic drones. Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic specializes in analog matrix processors that utilize unique compute-in-memory technology. Their products, including the M1076 Analog Matrix Processor and various PCIe and M.2 cards, integrate AI capabilities directly into compact chips, enabling desktop-level processing power in smaller devices. The company emphasizes its expertise in neural networks, processor architecture, and software design to deliver efficient AI solutions while maintaining performance, power efficiency, and accuracy in real-world environments.
Tecton
Seed Round in 2018
Tecton offers an enterprise-ready feature store that addresses the unique data requirements of machine learning. By providing a robust data platform, Tecton enables machine learning teams to efficiently build, serve, and scale features for production use. The platform allows users to construct features from various data sources, including batch, streaming, and real-time data, facilitating the sharing, reuse, and deployment of models. This capability empowers data scientists and organizations to automate decisions at high speed, enhance customer experiences, and transform business processes. Tecton's focus on optimizing the data layer for machine learning aims to help companies develop superior models more rapidly, driving significant business outcomes.
Primer
Series B in 2018
Primer Technologies, Inc., established in 2014 and headquartered in San Francisco, specializes in developing software that leverages machine learning and natural language processing to analyze vast amounts of textual data across multiple languages. Its platform automates the parsing and collation of documents, uncovering insights and generating reports comparable to those produced by human analysts. This enables governments and corporations to better understand and monitor global information, facilitating informed decision-making.
Visla Labs
Seed Round in 2018
Visla Labs Inc. is a San Francisco-based startup focused on developing an artificial intelligence platform tailored for the radiology and healthcare sectors. Incorporated in 2018, the company is dedicated to advancing healthcare technology, aiming to create innovative solutions that enhance diagnostic processes and patient care. With venture capital backing, Visla Labs is positioned for significant growth as it approaches a critical milestone in its development.
Bright Machines
Series A in 2018
Bright Machines, Inc. is a manufacturing company founded in 2018 and based in San Francisco, California, with additional offices in Tel Aviv, China, and Mexico. The company specializes in creating robotic arms and cells for micro factories, focusing on the assembly and inspection of electronic products. It aims to reduce manual labor in manufacturing by integrating advanced robotics with a software-defined manufacturing platform. This platform leverages artificial intelligence, machine learning, and production data to enhance automation processes, resulting in robots that are adaptable and equipped with sensor technology and computer vision. Bright Machines enables its clients to innovate rapidly and achieve better production yields at lower costs, meeting the evolving demands of the manufacturing sector.
Arraiy
Series A in 2018
Arraiy, Inc. is a company based in Palo Alto, California, focused on developing an AI-driven production platform for the motion picture and television industry. Founded in 2016 and formerly known as opencv.ai, Arraiy utilizes computer vision and machine learning to enhance the filmmaking process. The company collaborates with major studios, industry veterans, and award-winning artists to innovate visual storytelling and integrate real and virtual worlds seamlessly. Through its platform, Arraiy aims to empower creators with greater creative freedom and redefine the standards of visual content production. As of July 2020, Arraiy operates as a subsidiary of Matterport, Inc.
Mythic
Series B in 2018
Mythic Inc. is a technology company that designs and develops silicon chips and artificial intelligence processing units (IPUs) for a wide range of applications, from consumer electronics and wearables to autonomous vehicles and robotic drones. Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic specializes in analog matrix processors that utilize unique compute-in-memory technology. Their products, including the M1076 Analog Matrix Processor and various PCIe and M.2 cards, integrate AI capabilities directly into compact chips, enabling desktop-level processing power in smaller devices. The company emphasizes its expertise in neural networks, processor architecture, and software design to deliver efficient AI solutions while maintaining performance, power efficiency, and accuracy in real-world environments.
Primer
Series A in 2017
Primer Technologies, Inc., established in 2014 and headquartered in San Francisco, specializes in developing software that leverages machine learning and natural language processing to analyze vast amounts of textual data across multiple languages. Its platform automates the parsing and collation of documents, uncovering insights and generating reports comparable to those produced by human analysts. This enables governments and corporations to better understand and monitor global information, facilitating informed decision-making.
Primer
Venture Round in 2017
Primer Technologies, Inc., established in 2014 and headquartered in San Francisco, specializes in developing software that leverages machine learning and natural language processing to analyze vast amounts of textual data across multiple languages. Its platform automates the parsing and collation of documents, uncovering insights and generating reports comparable to those produced by human analysts. This enables governments and corporations to better understand and monitor global information, facilitating informed decision-making.
Recursion Pharmaceuticals
Series B in 2017
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.
Mythic
Series A in 2017
Mythic Inc. is a technology company that designs and develops silicon chips and artificial intelligence processing units (IPUs) for a wide range of applications, from consumer electronics and wearables to autonomous vehicles and robotic drones. Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic specializes in analog matrix processors that utilize unique compute-in-memory technology. Their products, including the M1076 Analog Matrix Processor and various PCIe and M.2 cards, integrate AI capabilities directly into compact chips, enabling desktop-level processing power in smaller devices. The company emphasizes its expertise in neural networks, processor architecture, and software design to deliver efficient AI solutions while maintaining performance, power efficiency, and accuracy in real-world environments.
Orbital Insight
Series C in 2017
Orbital Insight, Inc. is a geospatial analytics company based in Palo Alto, California, established in 2013. The firm develops a cloud-based platform that employs artificial intelligence and machine learning to analyze vast amounts of geospatial data, including satellite imagery, mobile location signals, and other Internet of Things data. This technology enables organizations, including businesses, governments, and NGOs, to gain insights into societal and economic trends that may not be visible to the naked eye. Orbital Insight's products, such as Orbital Insight GO, GO Consumer, and GO Energy, provide users with actionable intelligence regarding infrastructure, supply chain dynamics, and energy resources. By transforming billions of data points into clear, usable information, the company supports data-driven decision-making in various sectors.
Pinscreen
Seed Round in 2017
Pinscreen, Inc. is a technology company based in Santa Monica, California, specializing in advanced generative AI technologies for film production and interactive experiences. Founded in 2015 by Prof. Hao Li, the company offers innovative solutions for AI lip sync, face reenactment, face swaps, de-aging, and avatar digitization. Pinscreen collaborates with major filmmakers and production studios, including Netflix, Amazon Studios, and Warner Bros, among others. The company gained recognition for developing the first real-time deepfake technology, showcased at notable events such as the World Economic Forum in Davos and SIGGRAPH 2020. Additionally, Pinscreen was the first to demonstrate AI lip sync for a complete feature film and has the capability to process thousands of 4K HDR movie shots annually. Its technology allows for the creation of three-dimensional avatars from selfies, enhancing mixed reality experiences for consumers and providing scalable content creation tools for professionals. Pinscreen is also a participant in the NVIDIA Inception Program and received the Epic MegaGrants in 2020.
Arraiy
Seed Round in 2017
Arraiy, Inc. is a company based in Palo Alto, California, focused on developing an AI-driven production platform for the motion picture and television industry. Founded in 2016 and formerly known as opencv.ai, Arraiy utilizes computer vision and machine learning to enhance the filmmaking process. The company collaborates with major studios, industry veterans, and award-winning artists to innovate visual storytelling and integrate real and virtual worlds seamlessly. Through its platform, Arraiy aims to empower creators with greater creative freedom and redefine the standards of visual content production. As of July 2020, Arraiy operates as a subsidiary of Matterport, Inc.
Mythic
Series A in 2016
Mythic Inc. is a technology company that designs and develops silicon chips and artificial intelligence processing units (IPUs) for a wide range of applications, from consumer electronics and wearables to autonomous vehicles and robotic drones. Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic specializes in analog matrix processors that utilize unique compute-in-memory technology. Their products, including the M1076 Analog Matrix Processor and various PCIe and M.2 cards, integrate AI capabilities directly into compact chips, enabling desktop-level processing power in smaller devices. The company emphasizes its expertise in neural networks, processor architecture, and software design to deliver efficient AI solutions while maintaining performance, power efficiency, and accuracy in real-world environments.
Recursion Pharmaceuticals
Series A in 2016
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.
Clarifai
Series B in 2016
Clarifai, Inc. is a prominent provider of advanced artificial intelligence solutions specializing in image recognition, natural language processing, and audio recognition. Founded in 2013 by Matt Zeiler, Ph.D., the company develops a deep learning platform that enables organizations to convert unstructured data—such as images, videos, text, and audio—into structured data efficiently and accurately. Clarifai's image recognition technology is capable of detecting near-duplicates, categorizing objects, and tagging images, while also allowing users to search for similar images within extensive uncategorized collections through a combination of semantic and visual similarity. Additionally, the company offers a labeling tool called Labeler, which aids in dataset labeling, AI training, and model auto-scaling in production environments. Headquartered in New York, with an office in Tallinn, Estonia, Clarifai employs a distributed team across various countries, including the United States, Canada, Argentina, and India.
Recursion Pharmaceuticals
Series A in 2016
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.
Pinscreen
Seed Round in 2016
Pinscreen, Inc. is a technology company based in Santa Monica, California, specializing in advanced generative AI technologies for film production and interactive experiences. Founded in 2015 by Prof. Hao Li, the company offers innovative solutions for AI lip sync, face reenactment, face swaps, de-aging, and avatar digitization. Pinscreen collaborates with major filmmakers and production studios, including Netflix, Amazon Studios, and Warner Bros, among others. The company gained recognition for developing the first real-time deepfake technology, showcased at notable events such as the World Economic Forum in Davos and SIGGRAPH 2020. Additionally, Pinscreen was the first to demonstrate AI lip sync for a complete feature film and has the capability to process thousands of 4K HDR movie shots annually. Its technology allows for the creation of three-dimensional avatars from selfies, enhancing mixed reality experiences for consumers and providing scalable content creation tools for professionals. Pinscreen is also a participant in the NVIDIA Inception Program and received the Epic MegaGrants in 2020.
Orbital Insight
Series B in 2016
Orbital Insight, Inc. is a geospatial analytics company based in Palo Alto, California, established in 2013. The firm develops a cloud-based platform that employs artificial intelligence and machine learning to analyze vast amounts of geospatial data, including satellite imagery, mobile location signals, and other Internet of Things data. This technology enables organizations, including businesses, governments, and NGOs, to gain insights into societal and economic trends that may not be visible to the naked eye. Orbital Insight's products, such as Orbital Insight GO, GO Consumer, and GO Energy, provide users with actionable intelligence regarding infrastructure, supply chain dynamics, and energy resources. By transforming billions of data points into clear, usable information, the company supports data-driven decision-making in various sectors.
Rigetti Computing
Series A in 2016
Rigetti Computing is a full-stack quantum computing company that designs and manufactures quantum-integrated circuits, which are deployed in low-temperature environments. The company develops control systems that perform quantum logic operations and has created software to seamlessly integrate its quantum systems into existing cloud infrastructures. Rigetti is known for its development of the industry's first multi-chip quantum processor, enabling scalable quantum computing systems. Additionally, the company focuses on practical applications of quantum computing, particularly in computational chemistry and machine learning, and has introduced Forest, a comprehensive programming and execution environment for quantum and classical computing. The majority of its revenue is generated from the United States.
Nervana
Series A in 2015
Nervana is a technology company founded in 2014 and headquartered in San Diego, California. It specializes in machine learning and artificial intelligence, offering a software-as-a-service platform that enables businesses to develop custom deep learning applications. The company's flagship product, Nervana Cloud, provides a comprehensive software solution that utilizes deep learning techniques to facilitate the creation of intelligent applications. Founded by experts in various fields, including machine learning, neuroscience, and chip design, Nervana aims to simplify and scale the use of brain-inspired algorithms in technology development.
Clarifai
Series A in 2015
Clarifai, Inc. is a prominent provider of advanced artificial intelligence solutions specializing in image recognition, natural language processing, and audio recognition. Founded in 2013 by Matt Zeiler, Ph.D., the company develops a deep learning platform that enables organizations to convert unstructured data—such as images, videos, text, and audio—into structured data efficiently and accurately. Clarifai's image recognition technology is capable of detecting near-duplicates, categorizing objects, and tagging images, while also allowing users to search for similar images within extensive uncategorized collections through a combination of semantic and visual similarity. Additionally, the company offers a labeling tool called Labeler, which aids in dataset labeling, AI training, and model auto-scaling in production environments. Headquartered in New York, with an office in Tallinn, Estonia, Clarifai employs a distributed team across various countries, including the United States, Canada, Argentina, and India.
LensBricks
Seed Round in 2015
LensBricks INC is a technology company based in Bengaluru, India, specializing in the development and manufacturing of advanced camera systems for various sectors, including healthcare and defense. Founded in 2013 by experts in computational imaging and computer vision, the company focuses on enhancing customer awareness of household activities through innovative imaging solutions. By integrating camera hardware, software, and cloud technology, LensBricks aims to create unique visual experiences and provide valuable insights to its users. The company's commitment to democratizing imaging positions it at the forefront of the industry, leveraging its expertise to transform how visual data is captured and utilized.
Orbital Insight
Series A in 2015
Orbital Insight, Inc. is a geospatial analytics company based in Palo Alto, California, established in 2013. The firm develops a cloud-based platform that employs artificial intelligence and machine learning to analyze vast amounts of geospatial data, including satellite imagery, mobile location signals, and other Internet of Things data. This technology enables organizations, including businesses, governments, and NGOs, to gain insights into societal and economic trends that may not be visible to the naked eye. Orbital Insight's products, such as Orbital Insight GO, GO Consumer, and GO Energy, provide users with actionable intelligence regarding infrastructure, supply chain dynamics, and energy resources. By transforming billions of data points into clear, usable information, the company supports data-driven decision-making in various sectors.
Primer
Seed Round in 2015
Primer Technologies, Inc., established in 2014 and headquartered in San Francisco, specializes in developing software that leverages machine learning and natural language processing to analyze vast amounts of textual data across multiple languages. Its platform automates the parsing and collation of documents, uncovering insights and generating reports comparable to those produced by human analysts. This enables governments and corporations to better understand and monitor global information, facilitating informed decision-making.
Scaled Inference
Seed Round in 2014
Scaled Inference, Inc. is a Palo Alto, California-based company established in 2014 that specializes in artificial intelligence and machine learning. The firm develops a cloud-based platform tailored for third parties seeking to integrate advanced AI tools into their applications and services. This platform supports a variety of functions, including general-purpose pattern recognition, anomaly detection, and predictive ranking, allowing users to enhance their software systems, such as websites, mobile apps, and servers. By providing these capabilities, Scaled Inference enables clients to explore innovative applications and advance their computing efforts.
Orbital Insight
Seed Round in 2014
Orbital Insight, Inc. is a geospatial analytics company based in Palo Alto, California, established in 2013. The firm develops a cloud-based platform that employs artificial intelligence and machine learning to analyze vast amounts of geospatial data, including satellite imagery, mobile location signals, and other Internet of Things data. This technology enables organizations, including businesses, governments, and NGOs, to gain insights into societal and economic trends that may not be visible to the naked eye. Orbital Insight's products, such as Orbital Insight GO, GO Consumer, and GO Energy, provide users with actionable intelligence regarding infrastructure, supply chain dynamics, and energy resources. By transforming billions of data points into clear, usable information, the company supports data-driven decision-making in various sectors.
Inductive Bio
Inductive Bio specializes in providing a machine learning platform that enhances the compound optimization process for drug development. The company focuses on addressing ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) challenges by building comprehensive datasets and machine learning models. This enables scientists to efficiently identify and refine small molecule compounds, transforming initial candidates into viable leads more rapidly and with improved properties. By streamlining the optimization process, Inductive Bio supports the development of new therapeutics, ultimately contributing to advancements in the pharmaceutical industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.